> top > docs > PMC:7299399 > spans > 19432-19993 > annotations

PMC:7299399 / 19432-19993 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T89 104-108 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T90 118-122 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T91 145-150 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T193 68-69 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 93-100 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T195 155-156 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T196 283-285 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T128 145-150 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T129 151-154 Chemical denotes NPs http://purl.obolibrary.org/obo/CHEBI_50803
T130 524-526 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T85 0-561 Sentence denotes National Institutes of Health, enrolled the first participants into a Phase I clinical trial testing an mRNA vaccine (mRNA-1273) encapsulated in lipid NPs—a record time of just 63 days following sequence selection (NCT04283461).65 The enrollment of the first cohort of participants (18 to 55-year-old healthy subjects) concluded on April 16, 2020.66 CureVac and BioNTech (in partnership with Pfizer) are currently working on similar vaccines; Pfizer/BioNTech, in particular, have recently started the recruitment in Phase I/II trials (NCT04368728, NCT04380701).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
284 516-526 Gene denotes Phase I/II
286 50-62 Species denotes participants Tax:9606
287 269-281 Species denotes participants Tax:9606
291 145-150 Chemical denotes lipid MESH:D008055